Summary
The product Test Blend 250 mg/ml, manufactured by Asteroidbiotech, was independently tested for verification of its potency and composition. The sample, identified by Task Number #53178, was submitted by asteroidbiotech@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control.
The testing process began on 14 November 2024, with the sample received on 21 November 2024, and analysis completed on 26 November 2024. This report indicates that the product is slightly overdosed, but as with all manufacturer-submitted testing, independent third-party verification across multiple batches is recommended.
Detailed Report
Product Overview
- Manufacturer: Asteroidbiotech
- Product Name: Test Blend 250 mg/ml
- Active Ingredients: Multiple Testosterone Esters
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Testing Details
- Task Number: #53178
- Testing Ordered: 14 November 2024
- Sample Received: 21 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Asteroidbiotech (manufacturer)
- Analysis Paid For By: Asteroidbiotech (manufacturer)
Testing Results
- Testosterone Propionate – 32.25 mg/ml
- Testosterone Phenylpropionate – 66.36 mg/ml
- Testosterone Isocaproate – 65.49 mg/ml
- Testosterone Decanoate – 103.44 mg/ml
Verification Details
Verification URL: https://janoshik.com/tests/53178_FTV9JMN2XSIE
Evaluation of Manufacturer-Submitted Testing
While this analysis suggests an accurately dosed product with a slight overage, it is important to acknowledge that the sample was submitted and funded by asteroidbiotech@proton.me. Manufacturers often select higher-quality batches for testing, which may not fully reflect the consistency of commercial products. Janoshik Analytical follows rigorous protocols, but additional third-party testing is always advisable to confirm the accuracy across multiple batches.
Conclusion
The analysis confirms that Test Blend 250 mg/ml is slightly overdosed, with a total testosterone ester concentration of 267.53 mg/ml. The distribution of esters aligns with the expected formulation. While this result suggests strong quality control for this batch, independent testing remains crucial to ensure long-term consistency.
This report is provided for educational and harm reduction purposes to help consumers make informed decisions about anabolic steroid products.
Disclaimer
This report is published for informational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
